Marquet Magda
SEC insider (Form 3/4/5 filer). CIK 0001631486. Director at First Tracks Biotherapeutics, Inc. (TRAX) and 3 other issuers. 26 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in SAN DIEGO, CA.
Companies Marquet Magda has filed insider reports for
- First Tracks Biotherapeutics, Inc. (TRAX): Director
- Arcturus Therapeutics Holdings Inc. (ARCT): Director
- Immix Biopharma, Inc. (IMMX): Director
- ANAPTYSBIO, INC (ANAB): Director
Marquet Magda
CIK: 0001631486
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
ExerciseDirect6K shares- - Jun 5, 2026ARCT
Arcturus Therapeutics Holdings Inc.
AwardDirectStock option (right to buy)
15K shares- - May 22, 2026IMMX
Immix Biopharma, Inc.
AwardDirect6.3K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
15K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
42K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
10.6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
5.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
784 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise | 6,030 | - | $0 | Direct |
| Jun 5, 2026 |  ARCT Arcturus Therapeutics Holdings Inc. | Award Stock option (right to buy) | 15,000 | - | - | Direct |
| May 22, 2026 |  IMMX Immix Biopharma, Inc. | Award | 6,250 | - | $0 | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 15,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 10,600 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 5,500 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 784 | - | - | Direct |
1-10 of 26 transactions